These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 32655268)
1. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis. Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268 [TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254 [TBL] [Abstract][Full Text] [Related]
3. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965 [TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types. Ogutmen Koc D; Bektas S Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437 [TBL] [Abstract][Full Text] [Related]
5. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859 [TBL] [Abstract][Full Text] [Related]
6. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China. Wang X; Zhang Q; Han F; Wu Y Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004 [No Abstract] [Full Text] [Related]
7. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667 [TBL] [Abstract][Full Text] [Related]
8. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE. Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795 [TBL] [Abstract][Full Text] [Related]
9. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study. Na YS; Kim SG; Cho SJ Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936 [TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems]. Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133 [TBL] [Abstract][Full Text] [Related]
11. OLGA- and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications. Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779 [TBL] [Abstract][Full Text] [Related]
12. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801 [TBL] [Abstract][Full Text] [Related]
13. Wu M; Feng S; Qian M; Wang S; Zhang K Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275 [TBL] [Abstract][Full Text] [Related]
14. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499 [TBL] [Abstract][Full Text] [Related]
15. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia. Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867 [TBL] [Abstract][Full Text] [Related]
16. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492 [TBL] [Abstract][Full Text] [Related]
17. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A Scand J Gastroenterol; 2019 Feb; 54(2):145-151. PubMed ID: 30700174 [TBL] [Abstract][Full Text] [Related]
18. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages. Kim YI; Kook MC; Cho SJ; Lee JY; Kim CG; Joo J; Choi IJ Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28940945 [TBL] [Abstract][Full Text] [Related]
19. A single vial is enough in the absence of endoscopic suspected intestinal metaplasia - less is more! Castro R; Esposito G; Libânio D; Afonso L; Annibale B; Dinis-Ribeiro M; Pimentel-Nunes P Scand J Gastroenterol; 2019 May; 54(5):673-677. PubMed ID: 31084230 [No Abstract] [Full Text] [Related]
20. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment. Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]